Parque Arauco S.A. (SNSE:PARAUCO)

Revance Therapeutics Income Statement

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Rental Revenue	339,144	316,776	264,313	231,156	169,859	125,852
Other Revenue	22,478	21,728	19,526	19,769	6,201	5,212
Total Revenue	361,622	338,504	283,838	250,925	176,060	131,064
Revenue Growth (YoY	14.73%	19.26%	13.12%	42.52%	34.33%	-38.41%
Property Expenses	65,910	61,772	53,310	43,163	36,963	31,698
Selling, General & Administrative	30,346	29,865	26,914	22,424	18,605	33,824
Other Operating Expenses	-243.8	264.74	-4,109	-532.23	1,276	8,721
Total Operating Expenses	98,390	95,833	77,325	65,055	56,844	74,243
Operating Income	263,232	242,671	206,513	185,870	119,216	56,821
Interest Expense	-60,396	-64,745	-57,520	-45,805	-41,299	-49,813
Interest & Investment Income	25,222	27,734	26,618	22,322	3,711	7,494
Currency Exchange Gain (Loss)	-244.22	-120.83	56.98	-643.74	-3,048	1,065
Other Non-Operating Income	-53,004	-47,122	-36,843	-84,391	-46,231	-23,767
EBT Excluding Unusual Items	174,809	158,417	138,825	77,353	32,349	-8,199
Gain (Loss) on Sale of Assets	0.07	2.44	15.07	2.77	1,062	737.16
Total Insurance Settlements	-3.67	42.22	163.24	410.25	-	17
Asset Writedown	50,799	50,846	43,288	106,484	35,874	23,532
Other Unusual Items	-628.03	-727.32	-1,791	-1,366	-812.66	-1,093
Pretax Income	224,976	208,580	180,500	182,884	68,472	14,994
Income Tax Expense	64,374	59,039	51,385	45,332	20,527	10,745
Earnings From Continuing Operations	160,602	149,542	129,115	137,552	47,945	4,249
Minority Interest in Earnings	-32,266	-28,970	-16,770	-36,520	-24,506	-2,402
Net Income	128,335	120,571	112,345	101,032	23,438	1,846
Net Income to Common	128,335	120,571	112,345	101,032	23,438	1,846
Net Income Growth	7.19%	7.32%	11.20%	331.05%	1169.53%	-98.02%
Basic Shares Outstanding	906	906	906	906	906	906
Diluted Shares Outstanding	906	906	906	906	906	910
Shares Change (YoY)	-	-	-	-	-0.47%	-
EPS (Basic)	141.69	133.12	124.04	111.55	25.88	2.04
EPS (Diluted)	141.69	133.12	124.04	111.55	25.88	2.03
EPS Growth	7.19%	7.32%	11.20%	331.05%	1174.79%	-98.02%
Dividend Per Share	40.000	40.000	40.000	25.000	20.000	-
Dividend Growth	-	-	60.00%	25.00%	-	-
Operating Margin	72.79%	71.69%	72.76%	74.07%	67.71%	43.35%
Profit Margin	35.49%	35.62%	39.58%	40.26%	13.31%	1.41%
EBITDA	264,466	246,104	209,235	188,336	121,385	60,588
EBITDA Margin	73.13%	72.70%	73.72%	75.06%	68.95%	46.23%
D&A For Ebitda	1,234	3,433	2,722	2,467	2,169	3,767
EBIT	263,232	242,671	206,513	185,870	119,216	56,821
EBIT Margin	72.79%	71.69%	72.76%	74.07%	67.71%	43.35%
Effective Tax Rate	28.61%	28.31%	28.47%	24.79%	29.98%	71.66%

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.